University Technology Offices Focus Effort On Overcoming Academic 'Cultural' Barriers

The Scientist 9[12]:1, Jun. 12, 1995 News University Technology Offices Focus Effort On Overcoming Academic 'Cultural' Barriers Now that efficient systems are in place for patenting, the matter at hand is surmounting concerns about the process among faculty By Lee Katterman Sidebars Using the Internet for Technology Transfer . . . Royalty-Sharing Formulas* of the Top 10 U.S. Universities . . . In little more than a decade, licensing of university technology h

Written byLee Katterman
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share


News

By Lee Katterman

A major barrier separating the academic and commercial worlds- -the stigma attached to "applied" research -- appears to be falling, say many university licensing professionals. That is what Lita Nelson sees happening. Nelson, director of the Technology Licensing Office at the Massachusetts Institute of Technology, observes that fewer faculty express the view that involvement in patents and licensing will "contaminate" them in the eyes of their colleagues and research sponsors. "I saw that attitude commonly 10 years ago, but not as much any more," she comments.


Scheduling Conflict: Albert Rubenstein notes that faculty operate on a different time scale from the corporate world.

Indeed, numerous indicators show that the payoff from university technology transfer is finally becoming substantial. "Disclosures [of faculty inventions] are increasing gradually, new patents are tracking that closely, and income from licensing is going up more rapidly," reports Joyce Brinton, director of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies